This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Toronto directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Demographic and Clinical Correlates of Consent in a Pediatric Ophthalmology Biobank.
Biopreservation and biobanking · 2026
Content validity assessment and modification of the FACE-Q craniofacial module for retinoblastoma survivors.
PloS one · 2026
Development of a patient advocate committee for a pediatric biobank.
Research involvement and engagement · 2026
Latest funding
- $10,000
Join us for a 'Cup of Tea': A Patient-led Research Dissemination Strategy for the Canadian Retinoblastoma Community
CIHR · 2022 · Principal investigator
- $10,000
Psychosocial Support for Retinoblastoma Patients and Families: Planning an Inclusive Study Recruitment Strategy
CIHR · 2022 · Principal investigator
- $20,000
Developing a Patient Partnership to Decrease Age and Stage of Retinoblastoma at Diagnosis
CIHR · 2019 · Principal investigator
7 publications.
Demographic and Clinical Correlates of Consent in a Pediatric Ophthalmology Biobank.
Argento F, Devlin M, Dorna S, Flegg K, Mallipatna A, Prunier M, Regan T, Ristevski I, Tarabey L, Dimaras H
Content validity assessment and modification of the FACE-Q craniofacial module for retinoblastoma survivors.
Khan F, Noronha R, Ristevski I, Prunier M, Savoie G, Striowski A, Mallipatna AC, Wong-Riff KWY, Ali A, Dimaras H
Development of a patient advocate committee for a pediatric biobank.
Argento F, Devlin M, Dorna S, Flegg K, Prunier M, Regan T, Ristevski I, Tarabey L, Dimaras H
Assessing patient engagement approaches in the development of patient reported outcome measures.
Khan F, Prunier M, Ristevski I, Trantalovski M, Dimaras H
Governance and public trust: a case study of the rare-pediatric eye cancer biobank.
Flegg K, Noronha R, Ristevski I, Mallipatna AC, O'Donoghue S, Tarling T, Watson P, Dimaras H
Development of a Patient-Centered Pathway of Care for Retinoblastoma Patients: A Mixed-Methods Pilot Study.
Ristevski I, Flegg K, Al-Hammadi M, Livingstone M, Dorna T, Low L, Robert J, Ulster A, Kletke S, Mallipatna A, Paton K, Dimaras H, Canadian Retinoblastoma Research Advisory Board
The Canadian retinoblastoma research advisory board: a framework for patient engagement.
Gelkopf MJ, Avramov I, Baddeliyanage R, Ristevski I, Johnson SA, Flegg K, Dimaras H
Join us for a 'Cup of Tea': A Patient-led Research Dissemination Strategy for the Canadian Retinoblastoma Community
Principal investigators: Dimaras, Helen; Ristevski, Ivana
Keywords: Dissemination; Pan-Canadian; Patient Engagement In Research; Retinoblastoma; Virtual
Psychosocial Support for Retinoblastoma Patients and Families: Planning an Inclusive Study Recruitment Strategy
Principal investigators: Dimaras, Helen; Ristevski, Ivana
Keywords: Pan-Canadian; Patient Engagement In Research; Psychosocial Support; Retinoblastoma; Study Recruitment
Developing a Patient Partnership to Decrease Age and Stage of Retinoblastoma at Diagnosis
Principal investigators: Dimaras, Helen; Ristevski, Ivana
Keywords: Awareness; Cancer Screening; Childhood Cancer; Eye Cancer; Patient Oriented Research; Patient Partnership; Priority Setting
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Helen Dimaras and Ivana Ristevski: 7 shared papers
- Helen Dimaras and Asim Ali: 6 shared papers
- Helen Dimaras and Richelle Baddeliyanage: 2 shared papers
- Helen Dimaras and Peter Watson: 1 shared paper
- Peter Watson and Ivana Ristevski: 1 shared paper
- Asim Ali and Ivana Ristevski: 1 shared paper
- Richelle Baddeliyanage and Ivana Ristevski: 1 shared paper
- Ophthalmology
- Clinical Public Health Division
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.